PharmaDeals

the world’s most comprehensive pharmaceutical and biotech deals database.

Latest News from Pharma Deals

Merrion to Develop Insulin Drugs with Novo

2008-11-24
Novo Nordisk signed an agreement to develop oral insulin analogues using Merrion Pharmaceuticals’ Gastrointestinal Permeation Enhancement Technology (GIPET) in a deal valued at €45 M (US$58 M). Novo Nordisk is seeking alternative strategies for diabetes after abandoning its inhaled insulin product.

PharmaDeals Review

Johnson & Johnson Strengthens its Biosurgical Position by Acquiring Omrix

2008-11-24
Johnson & Johnson (J&J) has gained a series of innovative biosurgical products with its acquisition of Omrix, its partner of five years, for US$438 M. The two companies already have a marketing agreement for Omrix’s flagship product, but with this acquisition, J&J can now use its marketing skills to sell other Omrix products while Omrix focuses on developing novel biosurgical products.

PharmaDeals Review

Cash-strapped TorreyPines Divests its Alzheimer’s Disease Developments

2008-11-18
In order to raise cash to progress its clinical developments, TorreyPines Therapeutics is disposing its Alzheimer’s developments through two recently signed deals. The beneficiaries are Eisai, which has acquired the genetics programme, and QR Pharma, which has licensed worldwide rights to three compounds, Posiphen™, bisnorcymcerine and phenserine.

PharmaDeals Review

Gilead Sciences: Ireland - Much More than just a Portal to the EU Market

2008-07-02
In this interview, Fintan Walton talks to Julie O'Neill, General Manager of Gilead Sciences Ltd

Pharma Television

Bookmarks

Bookmark PharmaDeals through one of these social networks.

What's New in PharmaDeals?

Have a look to see what is new and upcoming in the new PharmaDeals v2.

Take a look!

PharmaDeals Cartoons

PharmaDeals' popular cartoon series takes a light-hearted look at the pharma industry.

Browse the cartoons